PL341539A1 - Heterocyclic toxins of topoisomerases - Google Patents

Heterocyclic toxins of topoisomerases

Info

Publication number
PL341539A1
PL341539A1 PL98341539A PL34153998A PL341539A1 PL 341539 A1 PL341539 A1 PL 341539A1 PL 98341539 A PL98341539 A PL 98341539A PL 34153998 A PL34153998 A PL 34153998A PL 341539 A1 PL341539 A1 PL 341539A1
Authority
PL
Poland
Prior art keywords
sub
compounds
topoisomerases
toxins
heterocyclic
Prior art date
Application number
PL98341539A
Other languages
English (en)
Inventor
Edmond J Lavoie
Jun Sung Kim
Leroy Fong Liu
Original Assignee
Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers filed Critical Rutgers
Publication of PL341539A1 publication Critical patent/PL341539A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41921,2,3-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL98341539A 1997-12-31 1998-12-30 Heterocyclic toxins of topoisomerases PL341539A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7028797P 1997-12-31 1997-12-31
PCT/US1998/027822 WO1999033824A1 (en) 1997-12-31 1998-12-30 Heterocyclic topoisomerase poisons

Publications (1)

Publication Number Publication Date
PL341539A1 true PL341539A1 (en) 2001-04-23

Family

ID=22094368

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98341539A PL341539A1 (en) 1997-12-31 1998-12-30 Heterocyclic toxins of topoisomerases

Country Status (11)

Country Link
US (3) US6667302B2 (https=)
EP (1) EP1044199B1 (https=)
JP (1) JP2002509858A (https=)
CN (1) CN1299358A (https=)
AT (1) ATE402168T1 (https=)
AU (1) AU753268B2 (https=)
CA (1) CA2316221A1 (https=)
DE (1) DE69839781D1 (https=)
IL (1) IL136911A0 (https=)
PL (1) PL341539A1 (https=)
WO (1) WO1999033824A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002509858A (ja) * 1997-12-31 2002-04-02 ルトガーズ,ザ ステイト ユニバーシティ オブ ニュージャージー 複素環式トポイソメラーゼ毒化合物
CA2534649A1 (en) * 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
ZA200705872B (en) * 2005-01-14 2008-09-25 Genelabs Tecnologies Inc Indole derivatives for treating viral infections
AU2006218403A1 (en) 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. Fused heterocyclic compounds and their use as sirtuin modulators
US7855289B2 (en) 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
EP1910385B1 (en) 2005-08-04 2013-07-24 Sirtris Pharmaceuticals, Inc. Benzothiazoles and thiazolopyridines as sirtuin modulators
US8093401B2 (en) 2005-08-04 2012-01-10 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US8088928B2 (en) 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
WO2008073451A2 (en) * 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
TW200916472A (en) 2007-06-20 2009-04-16 Sirtris Pharmaceuticals Inc Sirtuin modulating compounds
EP2376502B1 (en) 2008-12-19 2015-06-17 GlaxoSmithKline LLC Thiazolopyridine sirtuin modulating compounds
JP6898255B2 (ja) 2015-05-28 2021-07-07 エコラボ ユーエスエー インコーポレイティド 2−置換イミダゾール及びベンズイミダゾール腐食抑制剤
CA2987248C (en) 2015-05-28 2023-09-26 Ecolab Usa Inc. Novel corrosion inhibitors
EP3314038B1 (en) 2015-05-28 2021-12-29 Ecolab Usa Inc. Purine-based corrosion inhibitors
AU2016267611B2 (en) 2015-05-28 2021-12-09 Ecolab Usa Inc. Water-soluble pyrazole derivatives as corrosion inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE26065E (en) 1966-07-19 Folybenzimidazoles and their preparation
US26065A (en) 1859-11-08 Improvement in cotton-gins
US2985661A (en) 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
CH420044A (de) 1964-09-01 1967-03-15 Ciba Geigy Verwendung von neuen Azol-Derivaten als optische Aufheller für textile organische Materialien
DE1670684A1 (de) * 1966-04-01 1970-12-03 Hoechst Ag Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
SU1530628A1 (ru) 1987-11-20 1989-12-23 Ленинградский Технологический Институт Им.Ленсовета Тригидрохлорид 2-[2-фенил-5(6)-бензимидазолил]-N-(3-диметиламинопропил)-5(6)-бензимидазолкарбоксамида в качестве флуоресцентного красител дл исследовани ДНК
JP2700475B2 (ja) 1988-07-30 1998-01-21 コニカ株式会社 非線形光学材料および非線形光学素子
US5106863A (en) 1990-03-26 1992-04-21 Ortho Pharmaceutical Corporation Substituted imidazole and pyridine derivatives
US5767142A (en) 1996-03-20 1998-06-16 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
US5807874A (en) 1995-05-17 1998-09-15 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
NZ307959A (en) * 1995-05-17 1998-08-26 Univ Rutgers Substituted tribenzimidazole derivatives where the substituent can be aryl or heteroaryl and medicaments
US5770617A (en) * 1996-03-20 1998-06-23 Rutgers, The State University Of New Jersey Terbenzimidazoles useful as antifungal agents
JP2002509858A (ja) * 1997-12-31 2002-04-02 ルトガーズ,ザ ステイト ユニバーシティ オブ ニュージャージー 複素環式トポイソメラーゼ毒化合物
US6063801A (en) * 1998-02-12 2000-05-16 Rutgers, The State University Of New Jersey Heterocyclic topoisomerase poisons

Also Published As

Publication number Publication date
AU753268B2 (en) 2002-10-10
CA2316221A1 (en) 1999-07-08
US20040082637A1 (en) 2004-04-29
WO1999033824A1 (en) 1999-07-08
EP1044199B1 (en) 2008-07-23
CN1299358A (zh) 2001-06-13
JP2002509858A (ja) 2002-04-02
IL136911A0 (en) 2001-06-14
ATE402168T1 (de) 2008-08-15
US6667302B2 (en) 2003-12-23
US6995154B2 (en) 2006-02-07
US20080004280A1 (en) 2008-01-03
DE69839781D1 (en) 2008-09-04
US20020151575A1 (en) 2002-10-17
EP1044199A1 (en) 2000-10-18
AU2022099A (en) 1999-07-19

Similar Documents

Publication Publication Date Title
PL341539A1 (en) Heterocyclic toxins of topoisomerases
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
MXPA04001323A (es) Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso.
KR930003912A (ko) 울혈성 심장 마비 치료법
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
NO20006221L (no) Fremgangsmåte for bekjempelse av skadedyr
EA200100983A1 (ru) Производные 13-метилэритромицина
DK1485359T3 (da) Natriumkanalblokkere
SI2017276T1 (sl) Fenil-karboksamidne spojine, uporabne za tretiranje bolečine
EA199901016A1 (ru) 9-оксим-производные эритромицина
PT928788E (pt) Compostos farmaceuticamente activos
ATE156818T1 (de) Polyfluoralkylthiopoly(ethylimidazolium)- verbindungen, verfahren zu ihrer herstellung und ihre verwendung als biozide mittel
EE200000472A (et) Kasvajavastased toimeained
EP1228072A4 (en) PDGF RECEPTOR KINASE INHIBITING COMPOUNDS, THEIR PRODUCTION, CLEANING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
SI1000034T1 (en) Substituted 6-alkylphenanthridines
TW376301B (en) Fungicidal compositions
DE69330601D1 (de) Serotoninergische ergolin derivate
PL317349A1 (en) Organic compounds
DE69209164D1 (de) Alkylthiopoly(Ethylimidazolium)verbindungen, Verfahren zur Herstellung und deren Verwendung als Biozidemittel
DE69900297D1 (de) Akarizid und insektizid wirksame, substituierte Pyrimidine und Verfahren zu ihrer Herstellung
EA200001107A1 (ru) ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ
BR9508979A (pt) Carboxamidas bicíclicas como antagonistas de 5-ht1a
EA200101050A1 (ru) Замещенные бензолактамные соединения
CA2309485A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus